Responses
Therapeutics
DANAMI-2 randomised controlled trial
Primary percutaneous coronary intervention in ST-segment elevation myocardial infarction is more effective than fibrinolysis at reducing the composite outcome of death or reinfarction after 8 years
Compose a Response to This Article
Other responses
No responses have been published for this article.